632 POSTER Randomized phase II study of BMS-247550 (NSC 710428) given daily X 5 days or weekly in patients with metastatic or recurrent squamous cell cancer of the head and neck: E2301
2006 ◽
Vol 4
(12)
◽
pp. 190-191
◽
Keyword(s):
Phase Ii
◽